Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_assertion type Assertion NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_head.
- NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_assertion description "[They are attractive candidates for liver cancer therapy given that GPC3 and mesothelin show high expression in HCC and CCA, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_provenance.
- NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_assertion evidence source_evidence_literature NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_provenance.
- NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_assertion SIO_000772 21942912 NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_provenance.
- NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_assertion wasDerivedFrom befree-2016 NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_provenance.
- NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_assertion wasGeneratedBy ECO_0000203 NP925947.RARo0r-yWtdIY81gB15L3HDDFp3TiFcRsn44sMJrzPASo130_provenance.